Santen Pharmaceutical Co Ltd
TSE:4536

Watchlist Manager
Santen Pharmaceutical Co Ltd Logo
Santen Pharmaceutical Co Ltd
TSE:4536
Watchlist
Price: 1 617 JPY -0.71% Market Closed
Market Cap: 521.1B JPY

Intrinsic Value

The intrinsic value of one Santen Pharmaceutical Co Ltd stock under the Base Case scenario is 2 294.01 JPY. Compared to the current market price of 1 617 JPY, Santen Pharmaceutical Co Ltd is Undervalued by 30%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
2 294.01 JPY
Undervaluation 30%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Santen Pharmaceutical Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about Santen Pharmaceutical Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Santen Pharmaceutical Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Santen Pharmaceutical Co Ltd.

Explain Valuation
Compare Santen Pharmaceutical Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Santen Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Santen Pharmaceutical Co Ltd

Current Assets 195.1B
Cash & Short-Term Investments 66.1B
Receivables 62.8B
Other Current Assets 66.3B
Non-Current Assets 194B
Long-Term Investments 21B
PP&E 74.8B
Intangibles 77.6B
Other Non-Current Assets 20.6B
Current Liabilities 73.6B
Accounts Payable 30.6B
Other Current Liabilities 43B
Non-Current Liabilities 40.8B
Long-Term Debt 35.6B
Other Non-Current Liabilities 5.2B
Efficiency

Free Cash Flow Analysis
Santen Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Santen Pharmaceutical Co Ltd

Revenue
291.5B JPY
Cost of Revenue
-126.1B JPY
Gross Profit
165.3B JPY
Operating Expenses
-124.4B JPY
Operating Income
40.9B JPY
Other Expenses
-9.5B JPY
Net Income
31.4B JPY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Santen Pharmaceutical Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
ROE is Increasing
Exceptional Gross Margin
Strong 3Y Average Gross Margin
56/100
Profitability
Score

Santen Pharmaceutical Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Santen Pharmaceutical Co Ltd's solvency score is 89/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
89/100
Solvency
Score

Santen Pharmaceutical Co Ltd's solvency score is 89/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Santen Pharmaceutical Co Ltd

Wall Street analysts forecast Santen Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Santen Pharmaceutical Co Ltd is 2 117.23 JPY with a low forecast of 1 717 JPY and a high forecast of 2 730 JPY.

Lowest
Price Target
1 717 JPY
6% Upside
Average
Price Target
2 117.23 JPY
31% Upside
Highest
Price Target
2 730 JPY
69% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Santen Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Santen Pharmaceutical Co Ltd stock?

The intrinsic value of one Santen Pharmaceutical Co Ltd stock under the Base Case scenario is 2 294.01 JPY.

Is Santen Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 1 617 JPY, Santen Pharmaceutical Co Ltd is Undervalued by 30%.

Back to Top